24,400 results on '"ACUTE LUNG INJURY"'
Search Results
2. Acetaminophen and Ascorbate in Sepsis: Targeted Therapy to Enhance Recovery (ASTER)
3. Post-intensive Care Follow-up of Patients Hospitalized for an Acute Respiratory Distress Syndrome Caused by COVID-19 (RE-CoV-ERY)
4. Alveolar Recruitment Maneuvers, Intracerebral Hemodynamic and Oxygenation (M'RHICO)
5. Safety and Efficacy Evaluation of CO2 Removal in Combination with Continuous Veno-Venous Hemodialysis/Hemodiafiltration Therapy (multiECCO2R)
6. The ICU LIBERATION Study (LIBERATION)
7. Early Use of Prone Position in ECMO for Severe ARDS
8. Fostamatinib for Treating Acute Respiratory Distress Syndrome (ARDS) in Hospitalized Adults (FOSTA-ARDS)
9. International Survey for EXTubation Evaluation and Respiratory Dynamics in Acute Respiratory Distress Syndrome (EXTEND ARDS)
10. A Study Evaluating the Efficacy and Safety of IV L-Citrulline for the Prevention of Clinical Sequelae of Acute Lung Injury Induced by Cardiopulmonary Bypass in Pediatric Patients Undergoing Surgery for Congenital Heart Defects
11. Safety and Effectiveness of Placental Derived Exosomes and Umbilical Cord Mesenchymal Stem Cells in Moderate to Severe Acute Respiratory Distress Syndrome (ARDS) Associated With the Novel Corona Virus Infection (COVID-19)
12. Metoprolol in Acute Respiratory Distress Syndrome (MAIDEN) (MAIDEN)
13. A Study of GEn-1124 in Subjects with Acute Respiratory Distress Syndrome (ARDS)
14. Mesenchymal Stromal Cells For Acute Respiratory Distress Syndrome (STAT)
15. Efficacy and Safety of Antimicrobial Stewardship Intervention in Hospitalized COVID-19 Patients (COVASP) (COVASP)
16. Comparing Mechanical Power in Different Inspiratory Times
17. Study to Find the Highest Safe Dose of Soluble Guanylate Cyclase (sGC) Activator, BAY 1211163 Administered as Multiple Doses by Inhalation to Patients Who Cannot Breathe by Their Own and Suffer From a Type of Lung Failure That Causes Fluid to Build up in the Lungs Making Breathing Difficult (ARDS)
18. Physiological Studies in the Prone Position in Patients With ARDS
19. Comparison of Oxygenation Index and Oxygen Stretch Index
20. EndotyPIng PreHospitAl de Novo Acute hYpoxemic Respiratory Failure (EPIPHANY)
21. Inhaled Dornase Alpha to Reduce Respiratory Failure After Severe Trauma (TRAUMADORNASE)
22. Study of Cord Blood Derived Mesenchymal Stem Cells for Treatment of Moderate, Severe or Critical Pneumonia
23. Safety and Efficacy of Intravenous Wharton's Jelly Derived Mesenchymal Stem Cells in Acute Respiratory Distress Syndrome Due to COVID 19
24. MRG-001 as an Immunoregulatory and Regenerative Therapy for ARDS Patients (SUMMIT)
25. Neutrophil Phenotypic Profiling and Acute Lung Injury in Patients After Cardiopulmonary Bypass (CPB)
26. Use of hUC-MSC Product (BX-U001) for the Treatment of COVID-19 With ARDS
27. Dexmedetomidine Infusion and Postoperative Lung Aeration After Thoracic Surgery
28. Effects on Biotrauma of NMBAs and PP Association During ARDS (CURA-PRONE)
29. CytOSorb TreatMent Of Critically Ill PatientS Registry (COSMOS)
30. PROSpect: Prone and Oscillation Pediatric Clinical Trial
31. Repair of Acute Respiratory Distress Syndrome by Stromal Cell Administration (REALIST) (REALIST)
32. Safety Study of Inhaled Carbon Monoxide to Treat Pneumonia and Sepsis-Induced Acute Respiratory Distress Syndrome (ARDS)
33. Study of Safety and Efficacy of ALT-100mAb in Participants With Moderate/Severe ARDS
34. Rhu-pGSN for Acute Respiratory Distress Syndrome (ARDS)
35. Trial of Venovenous ECMO to De-Sedate, Extubate and Mobilise in Hypoxic Respiratory Failure (REDEEM)
36. Pediatric Acute Respiratory Distress Syndrome Asia Study (PARDS Asia)
37. Safety and Efficacy Study of Inhaled Carbon Monoxide to Treat Acute Respiratory Distress Syndrome (ARDS)
38. Electronic Nicotine Delivery Devices and Potential Progression to Acute Lung Injury (ENDALI)
39. Therapeutic Plasma Exchange Followed by Convalescent Plasma Transfusion in Severe and Critically Ill COVID-19 Patients
40. Alveolar fibroblast lineage orchestrates lung inflammation and fibrosis
41. Acute pulmonary injury in hematology patients supported with pathogen-reduced and conventional platelet components.
42. Causes and attributable fraction of death from ARDS in inflammatory phenotypes of sepsis.
43. Mitigation of acute lung injury by human bronchial epithelial cell-derived extracellular vesicles via ANXA1-mediated FPR signaling.
44. EIT Assessment of Overdistension in ARDS Patients in Prone Position (DISTIE-DV)
45. Anti-CD14 Treatment With IC14 in Hospitalized ARDS Patients
46. Inhaled Sevoflurane for ARDS Prevention (IPA)
47. Pre-hospital Ventilation Clinical Study
48. Nebulised Heparin to Reduce COVID-19 Induced Acute Lung Injury (CHARTER-Irl)
49. Effect of Prone Positionning in Non Intubated Patients
50. Effect of Different Depths of Neuromuscular Blockade on Respiratory Mechanics in Patients With Moderate-severe Acute Respiratory Distress Syndrome (ARDS)
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.